Wednesday, June 26, 2013

Patients at the Center of Healthcare

 By 

Posted:  
Tuesday, June 25, 2013 - 7:30pm
 
 
Dr. Michael and Rebecca Clark’s Lifespan Family Healthcare practice in Newcastle offers a patient-centered model of healthcare. SUE MELLO/Boothbay Register
As part of its decision to close the St. Andrews Hospital emergency room, Lincoln County Healthcare has proposed greater emphasis on primary and outpatient care.
Administrators and doctors have said they want to develop a Patient-Centered Medical Home (PCMH) model of care at the Family Care Center so that patients are healthier, better-served and actively engaged in their health and healthcare.
But what a patient-centered model looks like may still not be clear to many in the community.
On June 21, Dr. Michael Clark, one of the few private practice doctors in the region, provided members of LCH’s community advisory committee an overview of his experience with PCMH care.
In an interview last September, Clark said his desire for another approach to healthcare began when he was an employed physician in Washington, D.C.
“I was struck by a patient’s comment: ‘I love you; I hate your practice.’ And it was a good practice,” Clark said. “But there was a disconnect between what happened in the doctor’s office and outside of it.”
Closing that disconnect and developing a different culture of patient care were primary goals when Clark and his wife, Rebecca, a family and marriage therapist, opened their Lifespan Family Healthcare Center in 2005.
In 2009, Lifespan joined the Maine PCMH Pilot Program, part of a nationwide effort to assess the benefits of the model.
On Friday, Clark said the patient-centered model is designed to address some of the pitfalls of modern healthcare: a reimbursement system that rewards doing more rather than sustaining health, difficulty obtaining appointments and care when needed, fragmented and uncoordinated care, and practices that are centered around doctors’ schedules rather than patients’ needs.
How does PCMH work?
“The model isn’t that radical a concept,” Clark said. “It’s old-fashioned caring in a complex environment.”
To improve patients’ access to care, Clark said openings are intentionally left in the daily schedule to allow space for same-day visits, evening office hours are offered, and “virtual appointments” allow patients to obtain medication refills or have questions answered without an office visit.
Patients are also able to access information in their medical record, including test results, at any time through an Internet-accessed patient portal and they can use email to communicate with providers.
Essential to PCMH’s success is a team approach to care, Clark said. Each work day at Lifespan begins with a morning “huddle” to review the day’s schedule and patients’ needs. The team works to ensure that some of what might have formerly slipped through the cracks doesn’t. That process includes identifying and scheduling needed care, coordinating and tracking referrals, addressing the mental health needs of patients, and also includes a nurse care manager who regularly checks in with high-risk patients in their homes.
Although PCMH is in some ways a return to an earlier, holistic approach to healthcare, its success is reliant on modern technology. Clark characterized the transition to electronic medical records as painful for both clinicians and patients, but said the advantages far exceed the costs. Clark said electronic medical records allow for easier tracking of complex medical problems, help to prevent medication prescription errors, provide automatic reminders for overdue care, flag critical lab values and improve coordination among different specialists and healthcare facilities. Equally important, patients have the same access to all of their records as providers.
Clark said patients’ access to their electronic medical record makes the healthcare relationship more transparent and enables patients to become more active partners in their health. Shared responsibility for wellness is a key part of the PCMH model.
In the patient-centered model, the patient is not only expected to be an active participant in his or her own wellness, they are also invited to help in improving their care. Clark said Lifespan’s patients are regularly asked for feedback and a patient advisory council meets monthly to consider ways to enhance the practice.
“The advisory council has had a real influence on what we do and what we look like,” he said.
Clark said engaged and informed patients are the key to reforming healthcare. “The more I try to fix my practice, the more I believe it’s patients that will save healthcare,” he said. “Bringing patients on board, I think, is the only way we can do it.”
Clark recommends the July 2013 issue of Consumer Reports to anyone interested in more information on PCMH.
 

HHS proposes clarifications for market reform regulations and new exchange-related obligations but leaves key questions unanswered

McDermott Will & Emery
 
 
The proposed rule imposes new requirements on health insurance issuers offering Qualified Health Plans through Health Insurance Exchanges and clarifies other obligations for various market reforms and the Premium Stabilization Programs, despite the fact that applications to offer coverage through Exchanges already have been submitted and 2014 benefit packages and rates already have been developed. 
The U.S. Department of Health and Human Services (HHS) issued a proposed rule on June 14, 2013, (Proposed Rule) that offers new provisions and clarifications covering a wide range of topics relating to Health Insurance Exchanges, the Premium Stabilization Programs and other health insurance market reforms.  The Proposed Rule also imposes new requirements and obligations for state-based Health Insurance Exchanges (State Exchanges) and health insurance issuers offering Qualified Health Plans (QHPs) through State Exchanges and federally-facilitated Health Insurance Exchanges (FFEs, and collectively with State Exchanges, Exchanges), despite the fact that health plans’ applications to participate in Exchanges already have been submitted and enrollment begins in mere months. 
HHS leaves unanswered several critical questions, such as whether health insurance issuers offering QHPs (QHP Issuers) through FFEs will have an opportunity (and the time) to appeal HHS’s decision not to certify a QHP for the 2014 (or subsequent) benefit year.
Comments on the Proposed Rule, which was published in the Federal Register on June 19, 2013, are due to HHS on July 19, 2013.
HHS Introduces “Program Integrity” Provisions for Issuers and States
HHS imposes new operational and contracting requirements and enforcement mechanisms for QHP Issuers participating in FFEs.  The Proposed Rule also proposes new oversight and program integrity requirements for states operating their own risk adjustment and reinsurance programs as well as for State Exchanges.  These developments are not surprising, given HHS’s approach to administering the Medicare Advantage and Part D Programs, although some of the requirements seem to blur the distinction between HHS’s administration of federal entitlement programs versus federally-administered marketplaces.
Issuers Face New Compliance Obligations, Including Responsibility for Contractors
Borrowing from the Medicare Advantage and Part D Programs, HHS proposes new oversight and contractual requirements for QHP Issuers with regard to their contractors and subcontractors–“Delegated Entities” and “Downstream Entities” in Exchange parlance.  These definitions include providers of both administrative and health care services, and therefore are inclusive of hospitals, accountable care organizations and other health care providers with which QHP Issuers contract.  QHP Issuers are responsible for their own compliance with applicable federal and state standards as well as for the compliance of their Delegated and Downstream Entities, regardless of the relationship.  Additionally, QHP Issuers must incorporate into their contracts with Delegated and Downstream Entities certain provisions if the QHP Issuers delegate their activities or obligations.  These provisions include specification of the delegated activity and reporting responsibility, revocation of the delegated activity/reporting standard or other remedy if the Delegated/Downstream Entity’s performance is unsatisfactory and an obligation of the Delegated/Downstream Entity to retain books and records (and make them available to federal regulators) for 10 years.  New contracts entered into on or after October 1, 2013 must include these provisions, but QHP Issuers have until January 1, 2015 to amend existing agreements.
The QHP Issuers subject to these requirements are unclear.  The placement of the regulation, under Part 156, Subpart D relating to Federally-Facilitated Exchange Qualified Health Plan Issuer Standards, suggests the obligations are imposed only on QHP Issuers participating in FFEs.  The regulatory text and the preamble discussion, however, do not contain any such limitation and refer to “QHP issuers” more generally, suggesting all QHP Issuers are subject to the provisions, even if the QHP Issuers offer products through State Exchanges.  Issuers, providers and other contractors operating in states with State Exchanges may request clarification on this point.
Given Issuers’ extensive operations and the variety of Delegated and Downstream Entities with which Issuers may contract—including marketing organizations, agents, brokers, health care providers and administrative service providers—this proposal creates a significant burden on QHP Issuers, which now are directly accountable for the compliance (or non-compliance) of their contractors.  Many may wonder as to the need or appropriateness for HHS to dictate the terms of QHP Issuers’ contracts with their vendors when HHS’s role is to facilitate a health insurance marketplace, and not to arrange for the provision of health care benefits as is HHS’s responsibility under the Medicare Program.  Moreover, entities familiar with these obligations pursuant to Medicare Advantage and Part D operations also can attest to the significant practical challenges this responsibility imposes, including amending all provider and administrative contracts and negotiations when the other party does not know that these federal requirements must “flow downstream” to contractors.  A QHP Issuer also may determine that more extensive contractual requirements—such as a Delegated Entity’s maintenance of a compliance program—are necessary in order for the QHP Issuer to be comfortable with the entity’s performance of a delegated activity and compliance with laws.  Some contractors may take a partnership approach to their QHP Issuer relationships and accept these responsibilities, but others may object to assuming more expansive obligations than those required by HHS.
HHS also proposes new compliance obligations (and implications for non-compliance) for QHP Issuers relating to cost-sharing subsidies.  QHP Issuers are responsible for ensuring that members are assigned to the appropriate standard plan or silver plan variation and that the appropriate cost-sharing reductions are applied.  HHS believes that members should be held harmless if the QHP Issuer “misapplies” the cost-sharing reductions.  Accordingly, QHP Issuers are obligated to refund any excess cost-sharing paid by or on behalf of the member to the person or entity that paid the excess cost-sharing (“whether the enrollee or the provider”) no more than 30 calendar days after discovery of any improper allocation of cost-sharing.  Further, QHP Issuers are not eligible to be reimbursed for any excess cost-sharing reductions improperly furnished to the member, such as through the end-of-year reconciliation.  Beginning with the 2015 benefit year, QHP Issuers would be required to provide HHS (and the State Exchange, as applicable) a report detailing occurrences of the improper application of cost-sharing violations, failure to refund any excess cost-sharing amounts paid, and QHP Issuer reimbursement for excess cost-sharing provided.  HHS requests comment on this report proposal, including frequency of the report and a minimum error rate or threshold that would trigger the reporting obligation.
The Proposed Rule imposes a similar refund obligation, 30-day time period and reporting requirement on QHP Issuers relating to their failure to reduce the portion of the premium charged to or for a member for the applicable month(s) by the amount of the advance premium tax credit available to the individual.  Additionally, QHP Issuers must submit to HHS summary statistics with respect to administration of cost-sharing reductions and premium tax credits.
QHP Issuers participating in an FFE that undergo a change of ownership, as recognized by the state in which the FFE is operating, will notify HHS at least 30 days prior to the change in ownership.  The form and format of the notice will be determined, and will include the legal name and Taxpayer Identification Number of the new owner and the effective date of the change in ownership.  HHS also requires that the new owner agree to “adhere to all applicable statutes and regulations,” presumably relating to the offering of QHPs through the FFE.  HHS elected not to require a novation agreement, similar to that required for Medicare Advantage Organization/Part D Plan Sponsor changes in ownership, based on the conclusion that such a requirement would duplicate existing state requirements, but requests comments on this issue.
10-Year Record Retention and Government Inspection Obligations
HHS imposes on Issuers a series of record retention and government-inspection provisions for the reinsurance (as described below) and risk adjustment programs.  Records must be “sufficient” to enable the regulators (whether federal or state, depending on who administers the program) to evaluate compliance with applicable risk adjustment standards and retained for 10 years.  HHS specifically references data validation obligations as well as records relating to premium rating and small group status as subject to the record retention and audit provisions.  Given the potential for allegations of federal False Claims Act (FCA) violations that could arise in connection with either program and HHS’s statements in the Proposed Rule relating to the FCA, these proposals are not surprising.
These record retention and government inspection provisions are in addition to those proposed by HHS for QHP Issuers relating to their participation in FFEs.  QHP Issuers must maintain records that are sufficient to enable periodic auditing by HHS, including financial records relating to participation in Exchanges (including auditing for financial solvency) and compliance reviews.  Risk corridor payment records, although not referenced, seem as though they could be included in the scope of this record retention requirement.  Interestingly, HHS imposes these record retention requirements on QHP Issuers participating in FFEs, and includes a separate record retention provision for QHP Issuers operating in State Exchanges for documents relating to application of cost-sharing subsidies and premium tax credits.  It is not clear, however, that HHS imposes on QHP Issuers participating in State Exchanges, or requires State Exchanges to impose on QHP Issuers participating in State Exchanges, the more expansive record retention and government audit obligations.
HHS Oversight and Enforcement Action in FFEs
The Proposed Rule codifies HHS’s prior statements, including in the FFE Application, regarding its intent to conduct compliance reviews of QHP Issuers participating in FFEs.  Using a risk-based approach for selecting QHP Issuers to audit that includes analyses of data submitted by QHP Issuers, HHS will audit QHP Issuer records, systems and facilities relating to its participation in the FFE, including to
  • Evaluate compliance with Exchange standards and performance thereunder
  • Verify performance of the duties to which the QHP Issuer attested in its certification process
  • Assess the likelihood of fraud and abuse
HHS expects to focus its review on FFE standards for QHP Issuers “because oversight of market-wide standards will generally be performed by States as part of their regulatory oversight.”  HHS does not indicate whether it may take a more expansive approach in conducting audits in states where the state has elected not to enforce a standard or lacks the regulatory or enforcement authority to do so.  Although HHS expects the audits will be less rigorous than those applied to Medicare Advantage Organizations, audit findings will be incorporated into HHS’s process for evaluating whether permitting a QHP Issuer’s products to be available in an FFE is in the interest of the qualified individuals and qualified employers purchasing coverage through the FFE.  HHS may conduct audits up to 10 years from the last day of the applicable benefit year.
The Proposed Rule for the first time provides specific detail regarding HHS’s enforcement authority in administering FFEs.  Consistent with the authority granted under the Affordable Care Act (ACA), HHS sets out the bases upon which it would undertake the two “formal” enforcement actions against QHP Issuers: decertification and civil money penalties (CMPs).  HHS is silent regarding potential “informal” enforcement actions it may take against QHP Issuers, such as warning letters and corrective action plan requests imposed on Medicare Advantage Organizations and Part D Plan Sponsors.
  • Civil Money Penalties: Similar to its audit approach, HHS intends to focus its oversight on FFE standards and avoid unnecessary duplication of state regulatory oversight of market-wide standards.  CMPs of up to $100 per day for each individual adversely affected may be imposed for “misconduct” or “substantial non-compliance” with Exchange standards.  In applying CMPs, HHS will take into consideration various factors, including “that 2014 will be a transitional year for issuers offering QHPs,” previous and ongoing record of compliance, the level of the violation and its impact on affected individuals, and any aggravating or mitigating circumstances.  QHP Issuers will receive a notice of HHS’s intent to assess CMPs and will have the right to a hearing before an administrative law judge (ALJ) to address whether there is a basis for CMPs and whether the assessed amount is reasonable.
  • Decertification: Decertification, which HHS for the first time indicates may occur at the issuer or QHP level, may occur for one of several reasons, including substantial failure to comply with specific federal standards applicable to participation in an FFE.  HHS also adopts from the Medicare Advantage and Part D Programs two very general bases for decertification: substantial failure to comply with federal laws and regulations applicable to QHP Issuers in the FFE, and operating in a manner “that hinders the efficient and effective administration of an FFE.”  Under the standard decertification process, HHS will provide written notice of its intent to decertify a QHP/QHP Issuer to the Issuer, to members and to the department of insurance of the applicable state, indicating the effective date of certification (no earlier than 30 days from the notice date).  If HHS determines that the basis for decertification involves members’ ability to access necessary medical items or services or fraud, HHS may expedite decertification and impose an immediate effective date.  A right of appeal, including a hearing before an ALJ to evaluate whether a basis for decertification exists, will be available to QHP Issuers under both processes, although the hearing would occur after decertification (and the start of a special enrollment period for members) under the expedited process.
CMPs also may be imposed on Issuers for failure to comply with the terms and conditions of the risk adjustment and reinsurance programs.  For example, an Issuer that does not provide HHS with access to enrollee-level claims data or does not set up a “dedicated distributed data environment” for the risk adjustment and reinsurance programs may be subject to CMPs.
Financial Integrity and Oversight Requirements for States and State Exchanges
The Proposed Rule imposes a series of operational and reporting requirements on states and State Exchanges.  A state operating a reinsurance or risk adjustment program, for example, must submit to HHS—and make publicly available—summaries of the respective operations, and the programs also must be audited annually for financial and programmatic compliance by an independent qualifying auditing entity.  States’ reinsurance entities must account for monies received from HHS for reinsurance payments and administrative expenses, including claims for payment, payments made and incurred administrative expenses.  Records relating to the reinsurance and risk adjustment programs must be maintained for 10 years and be made available to federal authorities.  States must extend the obligation to their contractors as well.
State Exchanges similarly are subject to record retention and federal audit requirements and annual audit obligations.  They must submit various reports to HHS, including a financial statement and to-be-specified reports addressing eligibility, enrollment, performance monitoring and consumer satisfaction.  HHS also imposes auditing and reporting obligations specific to compliance with advance premium tax credit and cost-sharing reduction standards.
The Proposed Rule creates new requirements relating to privacy and security incidents and breaches for State Exchanges and “non-Exchange entities.”  For example, a one-hour reporting obligation (from discovery) for State Exchanges and non-Exchange entities associated with FFEs is imposed for “all privacy and security incidents and breaches” (as such terms are defined in the Proposed Rule and which differ from the HIPAA Security Rule definitions).  Non-Exchange entities associated with a State Exchange also must report all incidents and breaches to the applicable State Exchange, although HHS does not specify the terms of such reporting obligation.
Enhancing the Reinsurance Program’s Contributing Entity Provisions
The Proposed Rule offers several clarifying statements regarding responsibility for reinsurance contributions, in addition to imposing record retention requirements on contributing entities and Issuers offering reinsurance-eligible health insurance coverage.
Revised Definition of Contributing Entity
The definition of a “contributing entity” for the temporary reinsurance program is amended to include as a self-insured group health plan a group health plan that offers a benefit package that is partially self-funded and partially fully-insured when the insured coverage does not constitute major medical coverage (regardless of whether the self-insured coverage is major medical).  For example, a group health plan that offers a single benefit package for which the medical benefits are self-insured and the prescription drug coverage is fully-insured falls within the revised definition of a self-insured group health plan because the insured coverage is not major medical coverage.  Accordingly, the group health plan is responsible for reinsurance contributions, consistent with existing reinsurance contribution counting requirements.  The Proposed Rule further clarifies that if the insurance coverage in such a circumstance is major medical coverage, the Issuer is responsible for the contributions.
Multiple Coverage Scenarios
The Proposed Rule also allocates financial responsibility for reinsurance contributions in other scenarios involving various coverage options, including creating an exception to the general premise that an Issuer is not responsible for contributions when not offering major medical coverage.
  • The Proposed Rule addresses a potential circumstance in which a group health plan offers a single benefit package that involves multiple health insurance coverages offered by more than one Issuer, none of which alone constitutes major medical coverage but the totality of which meets this threshold.  Under the general principle that an Issuer is not responsible for reinsurance contributions when it does not offer major medical coverage to a group health plan, there potentially is no “contributing entity” financially responsible for the contributions in this situation.  Accordingly, HHS creates an exception, providing that if a group health plan’s benefit package includes multiple health insurance coverages, none of which constitutes major medical coverage, and if the group health plan does not provide self-insured coverage for such covered lives (other than for excepted benefits), then the Issuer offering the largest percentage of coverage among the policies makes reinsurance contributions for such covered individuals.  The Proposed Rule sets out the bases upon which the “largest percentage of coverage” is determined, including using the average premium per covered life as a metric.
  • Separately, the Proposed Rule clarifies financial responsibility for contributions when the group health plan offers more than one benefits option, at least one of which is fully-insured coverage and at least one of which is not fully-insured coverage (either because the group health plan or a non-Issuer assumes the risk).  Such a circumstance might arise if a group health plan provides a self-insured benefit package to the majority of its employees, but those employees working at a satellite facility in a separate geographic area are offered separate, fully-insured health insurance coverage (e.g., to ensure there is a sufficient provider network for the coverage).  In this instance, the Issuer is responsible for the reinsurance contributions for covered lives under the fully-insured option, while the group health plan is responsible for the reinsurance contribution associated with the coverage options that are not fully-insured.
Practical Challenges for Issuer Compliance
Issuers face several challenges for complying with federal regulations (such as coordinating the provision of summary of benefits notices) when offering fully-insured coverage to a group health plan that also makes available other coverage options (whether fully-insured, self-insured or otherwise).  These challenges, including obtaining complete and accurate information regarding the scope of coverages available under the group health plan, take on a greater significance under the temporary reinsurance program, however, because of the potential FCA risk that could arise if the Issuer knowingly or recklessly avoids a payment obligation to the federal government–a “reverse false claim.”
Acknowledging that Issuers may not have all of the information necessary to evaluate their reinsurance contribution obligation in connection with a particular group health plan, HHS requests comments on whether it should direct Issuers to seek a representation from the group health plan sponsor regarding the relative percentage of coverage offered by the Issuer.  Furthermore, all contributing entities must maintain documents and records relating to enrollment count for 10 years so that the federal government may verify reinsurance contribution amounts.  (A similar obligation is imposed on Issuers offering reinsurance-eligible plans that request reinsurance payments under the program.) Issuers may consider whether their contracts with group health plan sponsors (and the sales agents associated with the account) should impose more expansive obligations in order for the Issuers to receive the information required to determine their reinsurance contribution payment obligations (and have continued access to such information for the 10-year period).
Clarifications and Technical Modifications for Market Reform Regulations
HHS in February 2013 finalized the health insurance market reform regulations (Market Reforms Final Rule) effective for plan and policy years beginning on and after January 1, 2014. With the Proposed Rule, HHS modifies several of the Market Reforms Final Rule requirements.
  • Consistency Among the PHSA, ERISA, and the Code Definitions of Small and Large Employers: Finally addressing an issue that has proved challenging since the ACA’s enactment, HHS requests comments on what interpretations of the statute, if any, are necessary to ensure “smooth implementation” and address the inconsistency between the ACA-revised definitions of “small employer” and “large employer” in the Public Health Service Act and the corresponding definitions in the Employee Retirement Income Security Act and Internal Revenue Code, which were not so amended.
  • Association Coverage: 45 C.F.R. § 144.102(c), as amended by the Market Reforms Final Rule, states that health insurance coverage offered through an association to a member that is an employer sponsoring a group health plan with fewer than two participants who are current employees on the first day of the plan year is considered individual health insurance coverage, regardless of state law.  This description does not recognize that the ACA changed the definition of “small employer” to include an employer with an average of at least one employee.  The Proposed Rule therefore modifies the description of association coverage in 45 C.F.R. § 144.102(c) in order to be consistent with the definition of “small employer” and makes corresponding changes to various definitions.
  • Geographic Rating: Consistent with its April 26, 2013 guidance, HHS amends 45 C.F.R. § 147.102 to provide that geographic rating in the individual market is based on the primary policyholder’s address (regardless of the location of other individuals covered under the policy), and, in the small group market, the geographic rating is based on the group policyholder’s “principal business address.”
  • Calendar Year Coverage: HHS amends 45 C.F.R. § 147.104 to provide that, effective January 1, 2015, (i) all non-grandfathered coverage in the individual market, and (ii) all non-grandfathered coverage in a market for which the individual and small group risk pools have been merged must be offered on a calendar year basis.  This revision, which HHS states was the intent of the Market Reform Final Rule, aligns the coverage year for the non-Exchange and Exchange markets and is consistent with the single risk pool provisions.  Therefore 2014 becomes a “stub year” for policies issued or renewed in these markets after January 1, 2014, so that all policies issue/renew effective January 1, 2015.  Small group markets for which the risk pool has not been merged are unaffected by this change.
  • Rating Updates: HHS limits to once annually Issuers’ opportunity to modify their market-wide adjusted index rate and plan-specific pricing for individual markets and for markets in which the individual and small group risk pools are merged.  Issuers participating in the small group (only) market may make index rate and plan-specific pricing changes on an annual basis until HHS issues a notification that the Federally Facilitated Small Business Health Options Program (FF-SHOP) can process quarterly rate updates, after which adjustments may be made on a quarterly basis.          The preamble to the Proposed Rule and the proposed regulatory language contain some phrasing that may cause confusion as to which Issuers would be subject to the initial annual update restriction–all Issuers offering small group coverage (regardless of whether the coverage is offered through a SHOP, and regardless of whether the SHOP is an FF-SHOP), or only QHP Issuers offering products through an FF-SHOP.  This is an area on which Issuers may request further clarification from HHS.
http://www.lexology.com/library/detail.aspx?g=3464db98-f249-4f6e-a562-ee898f2a9749

Tuesday, June 25, 2013

Preparing For ICD-10: Staying Ahead Of The Compliance Curve


Last Updated: June 24 2013
Article by Dan Vogt
BerryDunn




Your deadline to implement ICD-10 is October 1, 2014. Beyond simply meeting compliance, this marks an opportunity to improve your delivery of data-supported health care outcomes.
ICD-10 may not be the flashiest aspect of the industry-wide effort to improve health care delivery, but it may be one of the most far-reaching. These codes touch almost every piece of the health care puzzle, from providers to payers. The challenge is that not everyone realizes the impact of the ICD-10 transition. The key is to understand how your organization is affected and how to identify which areas of operation will be impacted. You'll likely discover that your organization is highly impacted by ICD-10—nearly every area of your operations will be affected.
Background
The World Health Organization put forth the updated ICD-10 codes in 1990. Other countries adopted ICD-10 starting in the mid-90s. The US is set to transition to ICD-10 on October 1, 2014, for Diagnosis and Inpatient Procedure Codes
Why is the US switching to ICD-10?
ICD-9 contains outdated terminology that is inconsistent with current medical practice. The code structure of ICD-9 is limited for further expansion, and the ICD-9 codes lack detail and specificity compared with ICD-10. The push for data analysis, outcome-based healthcare, and claim processing automation requires a more detailed, expandable, and flexible coding set.
Who is affected by the ICD-10 compliance deadline?
Everyone covered by the Health Insurance Portability and Accountability Act (HIPAA) is required to successfully conduct health care transactions using ICD-10 codes. All the entities involved in health care delivery and management use ICD coding, including payers, banks, clearinghouses for claims, providers, outsources services, employers, insurance brokers, and the Treasury.
What is affected by the ICD-10?
Changes in the diagnosis codes and inpatient procedure codes will impact your organization. In the tables below you can see the increase in the number of codes, code composition, and code complexity. This change will touch nearly all areas of your organization from the revenue cycle and coding teams to your providers.
Diagnosis Codes
ICD-9-CM
ICD-10-CM
Field Length
3 – 5 Characters
3 – 7 Characters
Available Codes
Approx. 13,000
Approx. 68,000
Code Composition
Digit 1 = alpha or numericDigits 2 – 5 = numeric
Digit 1 = AlphaDigit 2 = NumericDigit 3 – 7 Alpha or Numeric
Inpatient Procedure Codes
ICD-9-CM
ICD-10-CM
Field Length
3 – 4 Characters
7 alpha-numeric characters; all are required
Available Codes
Approx. 3,000
Approx. 72,000
Code Composition
Not Applicable
Specific meaning for character position by classification (e.g., med surg, mental health, etc.)
Why should you care?
If you don't meet the 2014 deadline, your claims can't be processed. This is an impact to revenue that no organization can weather.
According to the CMS FAQs for ICD-10 Transition Basics, "Claims for all services and hospital inpatient procedures performed on or after the compliance deadline must use ICD-10 diagnosis and inpatient procedures codes. Claims that do not use ICD-10 diagnosis and inpatient procedure codes cannot be processed."
Putting ICD-10 into context
We recognize that in the world of health care, ICD-10 is just one of the many large efforts that you are undertaking right now. You're dealing with Meaningful Use, ACOs, health care reform, IT security, EHR Adoption, consolidation, state budgets challenges, and on and on. The good news is that ICD-10 is a manageable project if you move through it in a deliberate, thorough, and organized manner.
Potential Pitfalls
We caution you to watch out for some possible issues that could complicate your execution of the transition process.
The "Silo Effect"occurs when you treat ICD-10 as a department level project. We often hear ICD-10 described as an IT project or a coding project. In reality, it is an enterprise-wide effort and will require all departments to participate in some capacity. ICD-10 crosses all areas, and you don't want to let a database or a legacy process get overlooked in the inventory or transition.
A lack of granularity could lead to not assessing, testing, communicating, or training with enough detail or structure to fully identify areas of concern. This is a project that requires both a microscope and herding stick. You need to corral all of your departments to participate and then examine their operations at a pretty low level to determine how they will be impacted by ICD-10.
Be wary of relying too much on your vendor's statements of readiness. Just upgrading to the ICD-10-ready version of software is not enough. You'll have internal preparation activities, changes in business process, testing, and training. You also need to have a back-up plan in the event that your vendor does not meet the ICD-10 deadline.
The last possible pitfall is not engaging in enough planning, testing, and communication with your payers and partners. The testing, transition, and monitoring stages require work with your outside entities to determine whether the implementation steps you have taken independently will work together.
The Silver Lining

ICD-10 is a compliance initiative with a fast-approaching deadline, but it's also an opportunity to assess and improve the communication and practices across your whole organization. Check out our useful tool, Planning for Compliance, 5 Steps for Readiness.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

U.S. Unveils Health Care Web Site and Call Center

By 

WASHINGTON — The Obama administration announced new steps to expand coverage under the federal health care law on Monday, less than a week after the Government Accountability Office, a nonpartisan investigative arm of Congress, found that the federal government and many states were “behind schedule” in setting up marketplaces where Americans are supposed to be able to buy insurance.
The steps — establishing a Web site and a telephone call center to provide information to consumers — are in preparation for what the government anticipates will be a flood of people buying health insurance starting Oct. 1.
Kathleen Sebelius, the secretary of health and human services, said the call center would be in operation 24 hours a day. The phone number is 800-318-2596. The Web site, www.healthcare.gov, provides information promoting the 2010 health care law and describing new insurance options. The Web site and call center currently have only general information about coverage.
Details about the prices and benefits of health insurance plans to be offered by Blue Cross and Blue Shield and companies like Humana and Kaiser Permanente will be available later this summer. Consumers can file online applications starting Oct. 1. Coverage is to begin on Jan. 1, when most Americans will be required to have insurance.
In a statement, Ms. Sebelius said, “The new Web site and the toll-free number have a simple mission: to make sure every American who needs health coverage has the information they need to make choices that are right for themselves and their families or their businesses.”
The Congressional Budget Office predicts that seven million people will buy private insurance next year through marketplaces, or exchanges, while nine million people will gain coverage through Medicaid. By 2016, it says, the number of uninsured, now estimated at 56 million Americans, may be reduced by 25 million as a result of the law.
The federal government will be running insurance exchanges in more than half the states. The administration had said previously that the federal exchanges would be open — at least in 2014 — to any insurers that met basic federal standards.
But Ms. Sebelius, a former Kansas insurance commissioner, told reporters on Monday that “we will be negotiating for rates across the country.” She emphasized the federal role, saying that “we intend to do rate negotiation to make sure that plans are going to offer consumers the best possible choices.”
Federal officials said the negotiations would focus on rates that were much higher or much lower than those proposed by other insurers.
The Web site asks consumers for information about their household incomes, to determine if they may be eligible for federal subsidies, in the form of tax credits, to help pay premiums.
Ms. Sebelius said “we are very concerned” that low-income people in some states will not have access to either Medicaid or subsidies for the purchase of private insurance. However, she said, “there is no timetable” for states to expand Medicaid, and states that rejected the expansion of eligibility this year could reconsider next year.
The federal Web site acknowledges that some states are not expanding Medicaid. “Under the health care law,” it says, “states have the choice to cover more people.”
The Web site says that people eligible for Medicaid should not try to buy insurance in the exchange, because they will not receive subsidies. “A marketplace plan will be more expensive than Medicaid and usually won’t give you additional coverage or benefits,” it says. “You wouldn’t be eligible for any savings on marketplace insurance and would have to pay the whole cost.”
In states that do not expand Medicaid, insurance subsidies will generally be available to people with incomes from the poverty level up to four times that amount ($23,550 to $94,200 a year for a family of four). But in those states, the subsidies will not be available to some of the neediest — people with incomes below the poverty level who will generally not qualify for the new financial assistance with health insurance.
More than half of all people without health insurance live in states that are not planning to expand Medicaid.
Marketing insurance in those states “will be complicated,” Ms. Sebelius said.
Administration officials said the call center would eventually have 9,000 customer service representatives fielding calls. Consumers can also seek information in live Web chats.

http://www.nytimes.com/2013/06/25/health/us-unveils-health-care-web-site-and-call-center.html?partner=rssnyt&emc=rss

Report: Va. AG wants rest of Medicaid settlement payment from feds


RICHMOND, Va. (Legal Newsline) — Virginia Attorney General Ken Cuccinelli reportedly is pressing the U.S. Treasury Department to release the remaining $105 million due to the state for the attorney general’s office’s role as the lead investigator into a 2012 Medicaid fraud settlement.
In a letter to Cuccinelli earlier this month, the department said it would release a total of $115 million.
Cuccinelli
Cuccinelli
The office received the initial $10 million Wednesday, a spokesman for Cuccinelli told The Associated Press.
The Treasury’s Executive Office for Asset Forfeiture, or TEOAF, said in its June 5 letter it would give Cuccinelli’s office an initial check for $10 million, but would need more information on how the attorney general planned to use the money before releasing the rest, the AP reported.
A deputy attorney general for Cuccinelli, in a letter last week, told TEOAF that the office wants the entire $115 million, and that the department’s demand for information is inconsistent with its guidelines and past practice.
According to the AP, John Childrey wrote that special authorization is required only when the attorney general plans to use the money on something other than law enforcement.
But the department argues that TEOAF has followed the same guidelines in the case that it adheres to in all asset forfeiture cases.
“The Treasury Department’s authority to make sharing payments is discretionary, and it has decided to share forfeited funds in this case,” a Treasury spokesman said in an email Thursday.
“TEOAF has informed the Virginia Attorney General’s office that its share of proceeds in this case will represent the largest equitable share in the history of the Treasury Forfeiture Fund — an amount that will likely exceed $100 million. This is a very significant sum of money and we have an obligation to the American taxpayers, including those in Virginia, to ensure that these funds are used in an appropriate manner.”
The attorney general says he has been fighting for months to obtain the money from the fraud settlement.
During a press conference held earlier this month, Cuccinelli said Treasury officials originally told his office they wouldn’t turn over the money because of the sequestration — a set of automatic federal spending cuts that were triggered March 1.
“This is despite the fact that it’s not federal money, but money that a private defendant paid to settle a case — money which was to be turned over shortly thereafter to our office and the other agencies involved in the investigation,” he said.
“Now the hold-up is the IRS, which, according to the Treasury Department, refuses to complete its paperwork so the money can be properly distributed.
“The exact amount of the forfeiture was known since September 2011 and finalized in a May 2012 plea agreement. It doesn’t take a year to complete the paperwork.”
The $1.5 billion settlement reached with Abbott Laboratories in May 2012 was divided into $800 million in civil settlements with the federal government and the states, and $700 million in criminal fines and forfeitures.
Abbott allegedly promoted the prescription drug Depakote to control agitation and aggression in elderly dementia patients and to treat schizophrenia, even though the federal Food and Drug Administration never approved the drug for those uses.
The drug was approved by the FDA to treat epileptic seizures, bipolar mania and migraines.
Under the criminal portion, Abbott paid the federal government a criminal fine of $500 million, it paid $1.5 million to the Virginia Medicaid Fraud Control Unit for investigative costs, and it forfeited assets of $198.5 million to go to the investigative agencies for law enforcement purposes.
Virginia’s $115 million comes from that asset forfeiture money, which is required by federal regulations to be used for law enforcement purposes.
Cuccinelli says he plans to use the money for law enforcement equipment and training.
From Legal Newsline: Reach Jessica Karmasek by email at jessica@legalnewsline.com.

Profiting From Pain

NEWS ANALYSIS
THE use of narcotic painkillers, or opioids, has boomed over the past decade as drug makers and doctors have promoted them for a new use: treating long-term pain from back injuries, headaches, arthritis and conditions like fibromyalgia. Insurers have also grown to see pills as a cheaper way to treat chronic pain than other methods.
Multimedia
Some patients are greatly helped by opioids, a large family of medications. Among the more widely used opioids are oxycodone, which is found in Percocet and OxyContin, and hydrocodone, which is used in Vicodin. Other potent opioids include fentanyl and methadone. Narcotic painkillers are now the most widely prescribed class of medications in the United States, and prescriptions for the strongest opioids, including OxyContin, have increased nearly fourfold over the past decade.
There is increasing evidence, however, that such drugs, along with being widely abused, are often ineffective in treating long-term pain and can have serious consequences, particularly when used in high doses. Along with the risk of addiction, side effects can include psychological dependence, reduced drive, extreme lethargy and sleep apnea.
The economic costs associated with the painkiller boom have also proved enormous, giving rise to a host of unanticipated medical, legal and social costs. Over the past decade, the legal — and illegal — use of these drugs has given birth to new businesses and expanded existing ones. These include urine-screening tests to make sure patients are taking the drugs properly, added sales of addiction treatment drugs, growing emergency-room expenses, law-enforcement budgets and skyrocketing costs for insurers.
In the short run, treating a patient with an opioid like OxyContin, which costs about $6,000 a year, is less expensive than putting a patient through a pain-treatment program that emphasizes physical therapy and behavior modification. But over time, such programs, which run from $15,000 to $25,000, might yield far lower costs.
Here is a brief guide to the economics of opioids.
Barry Meier is a reporter who covers business and medicine for The New York Times and the author of the Times e-book “A World of Hurt: Fixing Pain Medicine’s Biggest Mistake.”

Monday, June 24, 2013

Collaboration Encouraged at Patient-Centered Diabetes Care Event


Published Online: Friday, June 21, 2013

A session hosted by the American Journal of Managed Care brought together an array of groups involved in managing and treating diabetes.

In order to best serve diabetes patients, all those involved in managing the condition—including physicians, pharmacists, health plans, policymakers, and drug developers—must have a seat at the table. To foster collaboration among a number of these groups, a session titled “Patient-Centered Diabetes Care: Future Directions” was held at the University of Chicago Law School on June 20. The session was hosted by the American Journal of Managed Care in conjunction with Precision Health Economics.

The event was timed to take place just before the beginning of the annual meeting of the American Diabetes Association (ADA), which is being held June 21 to 25 in Chicago. Earlier this year, the ADA announced the results of a study finding that the total economic burden of diabetes in the United States reached $245 billion in 2012, a 41% increase since 2007. In March 2013, the American Journal of Managed Care launched Evidence-Based Diabetes Management, an indexed news publication, to help create a shared forum for physicians, health plans, pharmaceutical leaders, and policymakers.

“When the ADA announced the rise in the financial and human toll that diabetes takes from our economy and from the lives of everyday Americans, it was alarming, but sadly, not entirely surprising,” said Brian Haug, president of Intellisphere Managed Markets, which publishes the American Journal of Managed Care and Evidence-Based Diabetes Management. “Because we are in close touch with the medical community and have been for nearly two decades, we were already responding to this crisis. This week’s meeting is a continuation of that response.”

The event’s keynote speaker was Anne Peters, MD, CDE, director of the clinical diabetes program at the University of Southern California. Panel discussions addressed topics including individualizing diabetes patient treatment, the effect of diabetes patient behavior on quality of care and outcomes, and methods of improving patient adherence to diabetes medications and therapies. In the closing address, Deneen Vojta, MD, senior vice president for business initiatives and clinical affairs at UnitedHealth Group, discussed how to develop relationships between health insurers and drug developers.

Pharmacists also have the potential to play an important role in improving diabetes treatment outcomes. A study published in the May 15, 2013, edition of the American Journal of Health-System Pharmacy found that type 2 diabetes patients who were treated by a team of providers including a clinical pharmacist were significantly more likely to reach blood glucose, LDL cholesterol, and blood pressure goals than those treated by a primary care physician alone. (Click here to read our article about this study.)

At Pharmacy Times, we offer regular coverage of news relating to diabetes treatment. Earlier this month, we covered a study published in BMJ finding that use of some statins can lead to increased risk of new-onset diabetes. In April, we covered the newly released diabetes treatment guidelines from the American Association of Clinical Endocrinologists.

The print edition of Pharmacy Times regularly features Diabetes Watch, a round-up of notable recent studies. Our May 2013 issue included a review of diabetes apps that harness the power of mobile technology to help patients monitor and improve their condition. And, for a comprehensive look at diabetes as it relates to pharmacy, our October 2012 Diabetes Issue is an invaluable resource.


http://mobile.pharmacytimes.com/news/Collaboration-Encouraged-at-Patient-Centered-Diabetes-Care-Event

St. Louis raising $100M to keep startups in town


June 23, 2013 11:09 am by  | 0 Comments
St. Louis arch
Old St. Louis wants to become hot with young startups.
Civic and business leaders are raising $100 million to kick the region’s burgeoning startup scene up a notch. Dubbed the Regional Entrepreneurship Initiative (REI), it seeks to attract venture capital over the next five years to support the “rapidly growing entrepreneurial ecosystem and high-growth startup activity” as well as fund new ventures.
“A year ago, I asked what we needed to provide the best environment to help our best startups grow, and the answer came back with a resounding ‘get them more money,’” said St. Louis County Executive Charlie A. Dooley. “Now we are saying we need the money and are putting an aggressive plan in place to raise that capital. This guaranties the best new companies will stay in St. Louis and thrive for years to come.”
St. Louis is not exactly what you’d call a startup hub. The dominant industries are manufacturing, healthcare, and shipping, and the city is home to large corporations like Anheuser-Busch, Enterprise Rent-A-Car, Purina, and Energizer. It may not be a “bastion of progressivism,” but this is beginning to change.
Local entrepreneur Aaron Perlut said that over the past couple years, the region’s business and entrepreneurial ecosystem has begun to dramatically evolve and flourish and is becoming a “tech town.” Technology job postings are on the rise, as are salaries, and St. Louis is attracting enough human, intellectual, physical, and financial capital to emerge as a center of innovation. A startup called LockerDome recently closed $6 million in Series A financing, “big data” company Appistry pulled in nearly $40 million from private investors, and CrowdSource.com closed $12.5 million.
“St. Louis is seeing an incredible amount of early-stage tech activity right now, which is leading to a strong funnel of great deals,” said Gabe Lozano, the chief executive officer of LockerDome. “Without question, we will be globally recognized as a top 10 city in technology within 10 years.”
Square cofounder Jim McKelvey is a St. Louis native and said that in the past, many St. Louis startups left the area to get their business off the ground, but now that migration is reversing. REI is designed to fuel this trend by attracting new talent and keeping native success stories home. This requires access to capital, which is one of the main roadblocks that entrepreneurs outside of the tech bubble face, and it’s one of the main reasons they head to the Valley.
The impact that a thriving startup scene can have on the economy is well known, and President Obama is a vocal supporter of initiatives that support technology and innovation. REI is not only about capital flow but also about strengthening St. Louis’s ecosystem as a whole. Other components include building a regional customer relationship management system (CRM) to track startup assistance, investment, and impact; developing a common measurement system to track results; creating marketing and communications campaigns aimed at expanding awareness and increasing participation from people inside and outside the region; establishing programs to include minority, female, veteran, and immigrant entrepreneurs; and setting up regional mentorship programs. The $100 million will also contribute funding to pre-seed companies as well as increase the availability of Series A venture capital.
REI received a $1.5 million grant from the U.S. Economic Development Administration, will be entered at AccelerateSTL.org, and includes a coalition of public and private sector leaders as well as the region’s leading entrepreneurs and venture capital community. Some of the existing players in the St. Louis scene include Cultivation Capital, Arch Angels, Billiken Angels, and iSELECT Fund. There are also the incubator programs Arch Grants and Capital Innovators.
The money hasn’t been raised yet, but the passion is there. It is, after all, a city with a lot to offer. It has the Gateway Arch, the Cardinals, and a wealth of American history. Plus, it’s home to the gooey butter cake, which for me is enticement enough to go.
This article originally appeared on VentureBeat


Read more: http://medcitynews.com/2013/06/st-louis-raising-100m-to-keep-startups-in-town/#ixzz2X8gqaIPM

Texas Makes Changes To Medicaid Laws And Programs


Last Updated: June 24 2013
Article by Kimberly J. Gold and Ellyn L. Sternfield




Texas Governor Rick Perry signed a series of bills into law last week modifying some of the state's Medicaid statutes and programs.  The laws will take effect on September 1, 2013.
While the legislation was purportedly aimed at enhancing the state’s ability to detect and prevent Medicaid fraud, waste, and abuse, in fact many of the statutory provisions were added to comply with federal mandates necessary to secure ongoing federal funding for the Texas Medicaid program to ensure  continued eligibility for incentive recoveries under its civil false claims act. 
The highlights of the new laws are as follows:
  • S.B. 746 brings the state's civil false claims act, the Texas Medicaid Fraud Prevention Act (TMFPA), into compliance with the federal requirement that the state statute be "at least as effective" in rewarding and facilitatingqui tam actions as the federal false claims act.  The U.S. Department of Health and Human Services Office of Inspector General gave Texas until September 1, 2013 to amend the TMFPA so that the state may continue toqualify for a 10-percentage-point increase in its share of recovery of civil Medicaid false claims judgments and settlements.
The bill extends false claims liability to any person who or entity that commits an "unlawful act" by conspiring to otherwise violate the TMFPA, or who conceals, avoids or decreases their obligations to repay funds to Medicaid.   The bill also makes procedural changes to the state civil false claims statute of limitations and public disclosure provisions, resulting in provisions that parallel those in the federal false claims act.
  • Another bill, S.B. 1803, amends the Texas Government Code to meet federal requirements allowing the state to continue receiving matching funds from the federal government for the state's Medicaid program. Among other provisions, the bill requires the Texas Medicaid program's Office of Inspector General to conduct preliminary investigations of any complaint of Medicaid fraud or abuse, mandates referrals of fraud to the Texas Medicaid Fraud Control Unit or other law enforcement entities, and requires the Medicaid program to impose a payment hold on claims for reimbursement when credible allegations of fraud exist.
  • S.B. 8 amends the Texas Government Code to require the Medicaid program to establish a data analysis unit intended to detect data trends and identify anomalies relating to compliance with Medicaid and Children's Health Insurance Program (CHIP) requirements.  The bill also limits the marketing activities of CHIP and Medicaid providers and changes the licensure of non-emergency medical transportation companies and emergency medical services providers, with a two-year moratorium on new licenses for emergency medical services providers beginning September 1, 2013.
  • H.B. 658 amends the Civil Practice and Remedies Code so that plaintiffs cannot collect post-judgment interest on any portion of a damages award that includes money subject to Medicare subrogation.  The bill responds to concerns that post judgment interest accrues in Medicare subrogation lien cases, causing defendants to pay additional costs due to the delay of a third party's issuance of a demand letter.
While at first blush the bills appear technical in nature, the result may be increased Medicaid program oversight and enhanced opportunities for whistleblowers and state enforcement authorities to bring Medicaid-based civil false claims actions in Texas.  These new laws, combined with the swelling ranks of Medicaid Recovery Audit Contractors and similar entities, mean that Texas health care providers will likely see more scrutiny of their Medicaid billing activities.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.